Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Amortization of Deferred Charges (2024 - 2025)

Hinge Health's Amortization of Deferred Charges history spans 2 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 57.56% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $43.3 million, changed N/A, while the annual FY2025 figure was $46.7 million, 56.0% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $14.2 million at Hinge Health, up from $12.6 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $14.2 million in Q4 2025 and bottomed at $7.5 million in Q3 2024.